CA9 and neoplasm: Besides this, CAIX inhibition can also be used in conjunction with radiotherapy, which has been demonstrated by the use of DH348, a nitroimidazole-based anti-CAIX inhibitor that not only reduced tumour growth in mice but also sensitized the tumours to radiotherapy [163].